BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 3856981)

  • 21. Urine cytology of primary and secondary urinary bladder adenocarcinoma.
    Bardales RH; Pitman MB; Stanley MW; Korourian S; Suhrland MJ
    Cancer; 1998 Dec; 84(6):335-43. PubMed ID: 9915134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses.
    Garbar C; Mascaux C; Wespes E
    Cytopathology; 2007 Apr; 18(2):79-83. PubMed ID: 17397491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Early diagnosis of bladder carcinoma].
    Mantur M; Jakubowska I; Kemona H
    Pol Merkur Lekarski; 2005 Feb; 18(104):173-5. PubMed ID: 17877124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A method of semiautomatic quantimetry in urinary cytology. Apropos of 28 cases].
    Visseaux-Coletto B; Adnet JJ
    Arch Anat Cytol Pathol; 1984; 32(6):339-48. PubMed ID: 6529266
    [No Abstract]   [Full Text] [Related]  

  • 25. [Adriamycin instillations in carcinoma in situ of the bladder].
    Edsmyr F; Anderson L; Esposti PL
    Urologe A; 1983 Sep; 22 Suppl():337-41. PubMed ID: 6685384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa.
    Zein T; Wajsman Z; Englander LS; Gamarra M; Lopez C; Huben RP; Pontes JE
    J Urol; 1984 Oct; 132(4):670-1. PubMed ID: 6471209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of patients with carcinoma in situ of the bladder.
    Koss LG
    Pathol Annu; 1982; 17 Pt 2():353-9. PubMed ID: 7182757
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of bladder washings and urine cytology in the diagnosis of bladder cancer.
    Trott PA; Edwards L
    J Urol; 1973 Dec; 110(6):664-6. PubMed ID: 4757548
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
    Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
    Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms.
    Murphy WM; Soloway MS; Jukkola AF; Crabtree WN; Ford KS
    Cancer; 1984 Apr; 53(7):1555-65. PubMed ID: 6697294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The place of urinary cytology in the diagnosis of urothelial tumors].
    Mansat A; Pontonnier F; Plante P; Vincent MF; Lagorce C
    Bull Assoc Anat (Nancy); 1983 Mar; 67(196):141-50. PubMed ID: 6640127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial evaluation of the bladder tumor antigen test in superficial bladder cancer.
    D'Hallewin MA; Baert L
    J Urol; 1996 Feb; 155(2):475-6. PubMed ID: 8558639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of postoperative cytology for the early diagnosis of incomplete resection of bladder tumors].
    Salinas Sánchez AS; Sola Pérez J; Ortuño Pacheco G; Moreno Avilés J; Tomás Ros M; Server Falgás G
    Actas Urol Esp; 1989; 13(3):185-9. PubMed ID: 2763884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Carcinoma in situ of the urinary bladder: a diagnostic and therapeutic challenge].
    Jakse G; Hofstädter F; Leitner G; Marberger H
    Urologe A; 1980 Mar; 19(2):93-9. PubMed ID: 7404893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytologic recognition of the urinary bladder tumors with special reference to the morphological difference between atypical cells exfoliated from papilloma and in situ cancer (author's transl)].
    Yamada T; Mitani G; Yokokawa M; Inada T; Owada F
    Rinsho Byori; 1973 Sep; 21(9):753-6. PubMed ID: 4796727
    [No Abstract]   [Full Text] [Related]  

  • 36. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
    Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
    J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinoma in situ of the urinary bladder. Clinical presentation, cytologic pattern and stromal changes.
    Boon ME; Blomjous CE; Zwartendijk J; Heinhuis RJ; Ooms EC
    Acta Cytol; 1986; 30(4):360-6. PubMed ID: 3461646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Value of exfoliative cytology of the urinary bladder in occult bladder cancer and in the control of treated cancers].
    Schmitz A; Meyer U; Kierfeld G; Küchemann K
    Urologe A; 1984 Sep; 23(5):278-80. PubMed ID: 6542269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is conventional urinary cytology still reliable for diagnosis of primary bladder carcinoma? Accuracy based on data linkage of a consecutive clinical series and cancer registry.
    Turco P; Houssami N; Bulgaresi P; Troni GM; Galanti L; Cariaggi MP; Cifarelli P; Crocetti E; Ciatto S
    Acta Cytol; 2011; 55(2):193-6. PubMed ID: 21325806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.